InvestorsHub Logo
Followers 31
Posts 3397
Boards Moderated 0
Alias Born 02/09/2017

Re: steel8000 post# 18251

Thursday, 05/28/2020 6:50:55 AM

Thursday, May 28, 2020 6:50:55 AM

Post# of 27660
From Stallergenes press release.

The results of this new study demonstrate the potential of COP-virosomes in allergy immunotherapy treatments. During these unprecedented times, Stallergenes Greer remains committed to furthering research to provide patients with long-lasting relief from the burden of allergies and improving their quality of life,” concluded Amer Jaber, Executive VP Operations Europe and President of Stallergenes SAS.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News